openPR Logo
Press release

Cancer Gene Therapy Market Poised for Significant Growth, Projected to Reach USD 3,142.2 Million by 2034 at a 5.6% of CAGR

12-13-2024 07:03 PM CET | Health & Medicine

Press release from: Future Market Insights

Cancer Gene Therapy Market

Cancer Gene Therapy Market

The global market for cancer gene therapy is expected to see substantial growth in the coming decade. Estimated at USD 1,822.2 million in 2024, the market is forecast to expand to USD 3,142.2 million by 2034, growing at a compound annual growth rate (CAGR) of 5.6%. This growth is driven by increasing demand for more targeted and personalized cancer treatments, as well as advancements in genetic therapies. Notably, oncolytic virotherapy, which generated USD 850.7 million in 2023, is emerging as a key contributor to this market expansion.

The cancer gene therapy market is largely fueled by the growing shift toward personalized medicines. Unlike traditional treatments like chemotherapy and radiation, which are broad and less precise, gene therapy targets the genetic mutations responsible for cancer's development. This tailored approach minimizes damage to healthy cells, reducing side effects and enhancing the efficacy of treatment. The increased focus on targeted therapies and drugs further supports this trend, with gene therapy offering new hope for patients by addressing cancer at its genetic root.

The rising global prevalence of cancer, coupled with increased investment in clinical trials and research, has accelerated the development of gene therapies. Financial investments in clinical-phase gene therapy research are intensifying, with a surge in clinical trial protocols moving through Phase I, II, and III towards regulatory approval. This boost in research and development is laying the groundwork for future innovations in gene therapies and expanding treatment options for cancer patients worldwide.

Key players in the gene therapy manufacturing industry are also investing in new technologies to streamline production and delivery. These investments, combined with the rapid pace of regulatory approvals, are catalyzing interest in gene therapies for cancer. As clinical trials continue to demonstrate the potential of these therapies, the cancer gene therapy market is poised for significant growth, offering promising treatment alternatives for patients and driving the next wave of cancer care innovation.

Request a Sample Report Now to get Premium Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-14971

Key Takeaways:

The global cancer gene therapy market is expected to grow from USD 1.82 billion in 2024 to USD 3.14 billion by 2034, with a CAGR of 5.6%.
Personalized treatments and targeted therapies are driving the demand for cancer gene therapy.
The market is seeing increased investment in research, clinical trials, and regulatory approvals.
Oncolytic virotherapy is a key segment, having generated USD 850.7 million in 2023.

Key Drivers of Market Growth

Increased Demand for Personalized Medicine: The shift towards personalized treatment options is a significant factor driving the growth of the cancer gene therapy market. Gene therapy specifically targets the genetic alterations responsible for cancer, offering a more tailored approach compared to traditional therapies like chemotherapy and radiation, which can affect healthy cells and lead to higher toxicity and side effects.
Rising Global Cancer Incidence: The increasing prevalence of cancer worldwide is propelling demand for innovative treatment solutions, including gene therapy. As cancer cases rise, the need for effective therapies that can address the complexities of the disease becomes critical.
Advancements in Research and Development: There has been a notable increase in financial investments in clinical research focused on gene therapy. This has led to a rapid expansion of clinical trial protocols across various phases (I, II, and III), facilitating the path to regulatory approvals and market entry for new therapies.
Technological Innovations: Continuous advancements in gene therapy techniques and delivery methods are enhancing the efficacy of treatments. Innovations such as improved vectors for gene delivery and novel therapeutic approaches are attracting interest from both researchers and healthcare providers.

Competitive Landscape

Substantial investments in the cancer gene therapy market are increasingly focused on collaboration and expansion to drive growth and strengthen market presence. Companies are prioritizing the acquisition of innovative technologies and products to enhance their offerings, while also pursuing strategic partnerships to expand their global footprint.

Recent Industry Developments in Cancer Gene Therapy Market

In June 2021, Eisai and Bristol Myers Squibb agreed to collaborate on the development and commercialization of Eisai's ADC, MORAb-202, for advanced solid malignancies.
In June 2021, GSK and iTeos Therapeutics collaborated to develop EOS-448, an anti-TIGIT monoclonal antibody that had previously been approved in phase 1 for advanced solid malignancies.

Key Players of Cancer Gene Therapy Industry

Merck KGaA
Novartis AG
AstraZeneca Plc.
BIOCAD
Crinetics Pharmaceuticals, Inc.
EffRx Pharmaceuticals S.A.
Euroscreen S.A.
Vicore Pharma AB
Amgen
Bristol-Myers Squibb
Cell Genesys Inc.
Adaptimmune Therapeutics plc.
Achieve Life Science Inc.
BioCanCell Ltd.
Genelux Corporation
Advantagene Inc.
GenVec Inc.
GlaxoSmithKline PLC
Amgen Inc.

Key Segments of Cancer Gene Therapy Industry

By Therapy:

In terms of therapy, the industry is divided into gene induced immunotherapy, oncolytic Virotherapy, gene transfer among others.

By Indication:

In terms of indication, the industry is segregated into breast cancer, ovarian cancer, liver cancer, pancreatic cancer, lung cancer, prostate cancer.

By Service Provider:

In terms of service provider, the industry is segregated into hospitals, clinical research laboratory, oncology institutes.

By Region:

Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East & Africa have been covered in the report.

Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:

Healthcare Regulatory Affairs Outsourcing Industry - https://www.futuremarketinsights.com/reports/healthcare-regulatory-affairs-outsourcing-market

Zika Virus Testing Industry - https://www.futuremarketinsights.com/reports/zika-virus-testing-market

Herpes Labialis Treatment Industry -https://www.futuremarketinsights.com/reports/herpes-labialis-treatment-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Gene Therapy Market Poised for Significant Growth, Projected to Reach USD 3,142.2 Million by 2034 at a 5.6% of CAGR here

News-ID: 3787511 • Views:

More Releases from Future Market Insights

Global Anesthesia Equipment Market to Reach USD 18.2 Billion by 2035
Global Anesthesia Equipment Market to Reach USD 18.2 Billion by 2035
The Anesthesia Equipment Market is witnessing robust growth, with its value estimated at USD 9.3 billion in 2025 and projected to nearly double to USD 18.2 billion by 2035. This growth trajectory represents a compound annual growth rate of 7.0%, driven by increasing surgical volumes, rising prevalence of chronic respiratory and cardiovascular disorders, and ongoing expansion of healthcare infrastructure. The market is undergoing transformative change, as both established manufacturers and
Intravascular Ultrasound Systems Market to Reach USD 1455.7 Million by 2035
Intravascular Ultrasound Systems Market to Reach USD 1455.7 Million by 2035
The intravascular ultrasound (IVUS) systems market is on track to record consistent growth over the next decade. Valued at USD 893.7 million in 2025, the market is expected to expand to USD 1455.7 million by 2035, reflecting a compound annual growth rate of 5.0%. With cardiovascular disease remaining one of the leading causes of mortality globally, the demand for advanced intravascular imaging technologies is escalating. IVUS systems, which provide real-time
Electric Power Sports Market to Reach USD 18.5 Billion by 2035
Electric Power Sports Market to Reach USD 18.5 Billion by 2035
The global Electric Power Sports Market is on a fast track to transformation, as consumers, manufacturers, and policymakers align on one powerful goal: sustainable, high-performance recreational experiences. Valued at USD 10.3 billion in 2025, the market is projected to expand to USD 18.5 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 6.0%. This momentum is set to generate an absolute dollar opportunity of USD 8.2 billion over
Hair Straightener Market Forecast to Reach USD 12.4 Billion by 2035 as Innovation and Consumer Demand Drive Growth
Hair Straightener Market Forecast to Reach USD 12.4 Billion by 2035 as Innovatio …
The global hair straightener market is entering a transformative growth phase, as industry leaders and emerging brands alike innovate to meet rising consumer demand for advanced hair styling solutions. Valued at USD 7.1 billion in 2025, the market is projected to reach USD 12.4 billion by 2035, registering a compound annual growth rate (CAGR) of 5.7% over the forecast period. Between 2025 and 2030, the market is set to rise steadily

All 5 Releases


More Releases for Gene

DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034" The DNA and Gene Cloning Services Market Size is valued
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period? The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal